IP Library › Granted Patent US 12,746,377
Granted Patent B2
US 12,746,377 · App. 18/313,249 · Granted Sep 29, 2026

Dynamically controlled cerebrospinal fluid shunt

Inventors: Samuel Robert Browd (Mercer Island, WA); Ryan J. Douglas (Seattle, WA); Aaron Olafur Laurence Philippsen (Victoria, CA); Mark Drlik (Victoria, CA)
Assignee: Oaya, Inc.
A61M27/006A61M2202/0464A61M2205/3331
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,746,377
App. No.
18/313,249
Granted
Sep 29, 2026
Kind
B2
Abstract

Apparatus and associated methods relate to smart shunt systems. In an illustrative example, a cerebrospinal fluid (CSF) shunt system includes an interface module and conduit(s) configured to provide selective fluid communication between a brain ventricle(s) and at least one reservoir. The interface module may be operably coupled to one or more control module(s). The control module(s) may, for example, be operably coupled to one or more actuator(s) and/or sensor(s) (e.g., in the interface module(s), external to the interface module(s)). The control module(s) may, for example, selectively operate one or more of the actuator(s) as a function of input received from one or more of the sensors based on one or more predetermined control profile(s). Various embodiments may advantageously dynamically (e.g., automatically) control physiological attributes (e.g., CSF attributes).

Claims (66)

1 . A cerebrospinal fluid shunt comprising:

a proximal conduit configured to be implanted in fluid communication at a distal end with a brain ventricle of a patient;

a distal conduit configured to be implanted in fluid communication at a distal end with a reservoir;

a dynamically controlled valve module operably coupled to the proximal end of the proximal conduit and the proximal end of the distal conduit, the dynamically controlled valve module selectively operable to permit fluid communication between the distal conduit and the proximal conduit;

a pressure sensor configured to detect a transient pressure in the ventricle;

one or more sensors operatively coupled to the proximal conduit and configured to collect physiological signals from the patient;

one or more actuators operatively coupled to the proximal conduit and configured to perform actions based on control signals; and,

a control module in operable communication with the dynamically controlled valve, the pressure sensor, the one or more sensors, and the one or more actuators, such that, in response to detecting a transient pressure event in the ventricle that meets at least one criterion determined as a function of a predetermined control profile, then the dynamically controlled valve is operated to provide a corresponding predetermined flow profile between the distal conduit and the proximal conduit, wherein the control module:

analyzes a pressure waveform generated by the pressure sensor to detect and characterize transient pressure events;

extracts diagnostic information from the transient pressure events;

adjusts operation of the dynamically controlled valve based on the diagnostic information;

collects multiple physiological signals from the one or more sensors;

operates the one or more actuators based on the physiological signals from the one or more sensors; and,

stores the physiological signals from the one or more sensors.

2 . The cerebrospinal fluid shunt of claim 1 , wherein:

the transient pressure event comprises a transient pressure maximum generated by bodily motion of the patient,

the at least one criterion comprises a pressure change over time threshold, and

the dynamically controlled valve is operated to at least partially interrupt flow from the ventricle into the reservoir.

3 . The cerebrospinal fluid shunt of claim 1 , wherein the dynamically controlled valve module comprises a plurality of valves.

4 . The cerebrospinal fluid shunt of claim 1 , wherein the reservoir comprises a body cavity.

5 . The cerebrospinal fluid shunt of claim 1 , further comprising a backflush reservoir, wherein:

the dynamically controlled valve module is further in selective fluid communication with the backflush reservoir; and,

the predetermined flow profile is further configured such that the dynamically controlled valve module is operated to cause fluid from the backflush reservoir to be discharged through at least the proximal end of the proximal conduit in response to the transient pressure event.

6 . The cerebrospinal fluid shunt of claim 1 , wherein the one or more sensors further comprise a volume monitor.

7 . A cerebrospinal fluid shunt comprising:

a proximal conduit configured to be implanted in fluid communication at a distal end with a brain ventricle of a patient;

a distal conduit configured to be implanted in fluid communication at a distal end with a reservoir;

a dynamically controlled valve module operably coupled to the proximal end of the proximal conduit and the proximal end of the distal conduit, the dynamically controlled valve module selectively operable to permit fluid communication between the distal conduit and the proximal conduit;

a pressure sensor configured to detect a transient pressure in the ventricle;

one or more sensors operatively coupled to the proximal conduit and configured to collect physiological signals from the patient;

one or more actuators operatively coupled to the proximal conduit and configured to perform actions based on control signals; and,

a control module in operable communication with the dynamically controlled valve, the pressure sensor, the one or more sensors, and the one or more actuators, such that, in response to detecting a transient pressure event in the ventricle that meets at least one criterion determined as a function of a predetermined control profile, then the dynamically controlled valve is operated to provide a corresponding predetermined flow profile between the distal conduit and the proximal conduit, wherein the control module:

analyzes a pressure waveform generated by the pressure sensor to detect and characterize transient pressure events;

extracts diagnostic information from the transient pressure events;

adjusts operation of the dynamically controlled valve based on the diagnostic information;

collects multiple physiological signals from the one or more sensors;

operates the one or more actuators based on the physiological signals from the one or more sensors; and,

stores the physiological signals from the one or more sensors; and,

an input/output module in operable communication with the control module, wherein the input/output module is configured to exchange signals with an external interface device.

8 . The cerebrospinal fluid shunt of claim 7 , wherein the one or more sensors further comprise an acoustic sensor.

9 . The cerebrospinal fluid shunt of claim 7 , wherein the one or more sensors further comprise a force sensor.

10 . The cerebrospinal fluid shunt of claim 7 , wherein the one or more sensors further comprise a spatial sensor.

11 . The cerebrospinal fluid shunt of claim 7 , wherein the one or more actuators further comprise a valve actuator.

12 . The cerebrospinal fluid shunt of claim 7 , wherein the one or more actuators further comprise a pump.

13 . The cerebrospinal fluid shunt of claim 7 , wherein the one or more actuators further comprise an optical emitter.

14 . A cerebrospinal fluid shunt comprising:

a proximal conduit configured to be implanted in fluid communication at a distal end with a brain ventricle of a patient;

a distal conduit configured to be implanted in fluid communication at a distal end with a reservoir;

a dynamically controlled valve module operably coupled to the proximal end of the proximal conduit and the proximal end of the distal conduit, the dynamically controlled valve module selectively operable to permit fluid communication between the distal conduit and the proximal conduit;

a pressure sensor configured to detect a transient pressure in the ventricle;

one or more sensors operatively coupled to the proximal conduit and configured to collect physiological signals from the patient;

one or more actuators operatively coupled to the proximal conduit and configured to perform actions based on control signals; and,

a control module in operable communication with the dynamically controlled valve, the pressure sensor, the one or more sensors, and the one or more actuators, such that, in response to detecting a transient pressure event in the ventricle that meets at least one criterion determined as a function of a predetermined control profile, then the dynamically controlled valve is operated to provide a corresponding predetermined flow profile between the distal conduit and the proximal conduit, wherein the control module:

analyzes a pressure waveform generated by the pressure sensor to detect and characterize transient pressure events;

extracts diagnostic information from the transient pressure events;

adjusts operation of the dynamically controlled valve based on the diagnostic information;

collects multiple physiological signals from the one or more sensors;

operates the one or more actuators based on the physiological signals from the one or more sensors; and,

stores the physiological signals from the one or more sensors; and

a filter module disposed in fluid communication with the proximal conduit and the distal conduit, such that the filter module is configured to filter cerebrospinal fluid as the cerebrospinal fluid flows therethrough.

15 . The cerebrospinal fluid shunt of claim 14 , wherein the one or more actuators further comprise an electrical emitter.

16 . The cerebrospinal fluid shunt of claim 14 , wherein the one or more actuators further comprise a pharmaceutical dispenser.

17 . The cerebrospinal fluid shunt of claim 14 , wherein the one or more actuators further comprise a pneumatic actuator.

18 . The cerebrospinal fluid shunt of claim 14 , wherein the one or more actuators further comprise a displacement actuator.

19 . The cerebrospinal fluid shunt of claim 14 , wherein the one or more actuators further comprise a switch.

20 . The cerebrospinal fluid shunt of claim 14 , wherein the one or more sensors further comprise a lab-on-a-chip sensor.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2026
From: NEUFLUENT LLC
To: BROWD, SAMUEL ROBERT; DOUGLAS, RYAN J.
Reel/Frame 073888/0618 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2026
From: BROWD, SAMUEL ROBERT
To: OAYA, INC.
Reel/Frame 073889/0207 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2026
From: DOUGLAS, RYAN J.
To: OAYA, INC.
Reel/Frame 073889/0960 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2025
From: BROWD, SAMUEL; DOUGLAS, RYAN; PHILIPPSEN, AARON; DRLIK, MARK
To: NEUFLUENT LLC
Reel/Frame 072442/0094 →
Continuity (6)
Provisional Application 63488412 · Mar 3, 2023
Provisional Application 63477158 · Dec 23, 2022
Provisional Application 63477162 · Dec 23, 2022
Provisional Application 63365407 · May 26, 2022
Provisional Application 63364253 · May 5, 2022
Related Publication 20230355937A1 · Nov 9, 2023
References Cited (62)
US 6432050B1 · Porat et al. · 2002 [cited by applicant]
US 6533733B1 · Ericson · 2003 [cited by examiner]
US 7618391B2 · Madsen et al. · 2009 [cited by applicant]
US 8333728B2 · Bertrand et al. · 2012 [cited by applicant]
US 8870787B2 · Yadav et al. · 2014 [cited by applicant]
US 8992456B1 · Powell · 2015 [cited by applicant]
US 9072865B2 · Negre et al. · 2015 [cited by applicant]
US 9138568B2 · Swoboda et al. · 2015 [cited by applicant]
US 10272188B1 · Geiger et al. · 2019 [cited by applicant]
US 10695484B1 · Radojicic · 2020 [cited by applicant]
US 11247030B2 · Browd et al. · 2022 [cited by applicant]
US 11458249B2 · Morse et al. · 2022 [cited by applicant]
US 20030032915A1 · Saul · 2003 [cited by examiner]
US 20030163079A1 · Burnett · 2003 [cited by examiner]
US 20040147871A1 · Burnett · 2004 [cited by examiner]
US 20050277865A1 · Gharib · 2005 [cited by examiner]
US 20090005720A1 · Ludin · 2009 [cited by examiner]
US 20090131850A1 · Geiger · 2009 [cited by applicant]
US 20090177279A1 · Luciano et al. · 2009 [cited by applicant]
US 20100130884A1 · Linninger · 2010 [cited by applicant]
US 20110004158A1 · Luciano et al. · 2011 [cited by applicant]
US 20110137182A1 · Bellezza et al. · 2011 [cited by applicant]
US 20120238936A1 · Hyde · 2012 [cited by examiner]
US 20130197422A1 · Browd · 2013 [cited by examiner]
US 20140207045A1 · Anand et al. · 2014 [cited by applicant]
US 20140288459A1 · Yadav et al. · 2014 [cited by applicant]
US 20150112211A1 · Purdy · 2015 [cited by applicant]
US 20160331897A1 · Anand et al. · 2016 [cited by applicant]
US 20160331949A1 · Lutz · 2016 [cited by examiner]
US 20160339216A1 · Lenihan et al. · 2016 [cited by applicant]
US 20170013622A1 · Taylor · 2017 [cited by applicant]
US 20170095649A1 · Vase et al. · 2017 [cited by applicant]
US 20170203084A1 · Lad et al. · 2017 [cited by applicant]
US 20170209056A1 · Browd et al. · 2017 [cited by applicant]
US 20180256911A1 · Funane et al. · 2018 [cited by applicant]
US 20200001059A1 · Campbell et al. · 2020 [cited by applicant]
US 20200046953A1 · Vase · 2020 [cited by applicant]
US 20200275948A1 · Anand et al. · 2020 [cited by applicant]
US 20210052811A1 · Wostyn · 2021 [cited by applicant]
US 20210052866A1 · Roberts et al. · 2021 [cited by applicant]
US 20210379344A1 · Hakim · 2021 [cited by examiner]
US 20220105322A1 · Riccardi et al. · 2022 [cited by applicant]
US 20220265974A1 · Saul et al. · 2022 [cited by applicant]
US 20220361764A1 · Sutin et al. · 2022 [cited by applicant]
US 20230132409A1 · Morse · 2023 [cited by examiner]
US 20230363711A1 · Theodore · 2023 [cited by examiner]
CN 110575573A · 2019 [cited by applicant]
ES 2694698A1 · 2018 [cited by applicant]
WO 2010112555A1 · 2010 [cited by applicant]
WO 2011114260A1 · 2011 [cited by applicant]
WO 2022016072 · 2022 [cited by examiner]
WO 2022055806A1 · 2022 [cited by applicant]
Gonzalez, M., Implantable Systems for Continuous Liquorpheresis and CSF Replacement, Feb. 10, 2017, 10 pages. [cited by applicant]
Guy, et al, CPAP pressure and flow data at 2 positive pressure levels and multiple controlled breathing rates from a trial of 30 adults, accessed Jan. 2, 2023,<https://bmcresnotes.biomedcentral.com/articles/10.1186/s131… [cited by applicant]
Hamilton, R., Using Multi-Modality Measurements to Investigate Intracranial Pressure Waveform Morphology in Patients with Normal Pressure Hydrocephalus, 2014, retrieved from the internet, <https://escholarship.org/uc/it… [cited by applicant]
Irras, Active Fluid Exchange, accessed Apr. 13, 2023, <https://irras.com/product/proprietary-active-fluid-exchange/>. [cited by applicant]
Irras, Hummingbird Quad ICP Monitoring with Drainage Placement Instructions, accessed Apr. 13, 2013, <https://irras.com/wp-content/uploads/2020/08/IR-4984-H610-insertion-guide-poster-horizontal-v6.pdf>. [cited by applicant]
Irras, Hummingbird Quad ICP Monitoring with Drainage, accessed Apr. 13, 2023, <https:/irras.com/product/hummingbird/hummingbird-quad-icp-monitoring-with-drainage/>. [cited by applicant]
Irras, Introducing Hummingbird, accessed Apr. 13, 2023, <https://irras.com/product/hummingbird/>. [cited by applicant]
Irras, Introducing IRRAflow®, accessed Apr. 13, 2023, <https://irras.com/product/introducing-irraflow/>. [cited by applicant]
PX-Medical, How we work and the technology we use, accessed May 18, 2022, <https://www.px-medical.com/en/technology>. [cited by applicant]
Yiallourou, et al, Continuous positive airway pressure alters cranial blood flow and cerebrospinal fluid dynamics at the craniovertebral junction, Jun. 13, 2015, 8 pages. [cited by applicant]